Definitive Healthcare/$DH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Definitive Healthcare
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
Ticker
$DH
Sector
Primary listing
Employees
782
Headquarters
Website
DH Metrics
BasicAdvanced
$309M
-
-$2.70
1.64
-
Price and volume
Market cap
$309M
Beta
1.64
52-week high
$5.68
52-week low
$2.15
Average daily volume
332K
Financial strength
Current ratio
1.648
Quick ratio
1.47
Long term debt to equity
40.548
Total debt to equity
43.274
Interest coverage (TTM)
-0.74%
Profitability
EBITDA (TTM)
44.985
Gross margin (TTM)
83.67%
Net profit margin (TTM)
-124.43%
Operating margin (TTM)
-3.82%
Effective tax rate (TTM)
6.44%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
-0.53%
Return on equity (TTM)
-67.34%
Valuation
Price to revenue (TTM)
1.367
Price to book
1.02
Price to tangible book (TTM)
-1.69
Price to free cash flow (TTM)
8.113
Free cash flow yield (TTM)
12.33%
Free cash flow per share (TTM)
0.366
Growth
Revenue change (TTM)
-5.24%
Earnings per share change (TTM)
-22.19%
3-year revenue growth (CAGR)
8.07%
3-year earnings per share growth (CAGR)
101.72%
What the Analysts think about DH
Analyst ratings (Buy, Hold, Sell) for Definitive Healthcare stock.
Bulls say / Bears say
Definitive Healthcare reported Q2 2025 revenue of $60.8 million—a 5% year-over-year drop—but topped the high end of its guidance and raised its full-year revenue forecast, reflecting operational resilience.
Stifel increased its price target to $6, citing better customer retention and strong profitability, including an 83.4% gross profit margin and 31% adjusted EBITDA margin in Q2 2025.
The board’s approval of a $100 million share repurchase program through December 2025 signals management’s confidence in the company’s cash generation and belief the stock is undervalued.
Definitive Healthcare’s Q1 2025 revenue fell 7% year-over-year to $59.2 million, highlighting persistent top-line pressure and potential ongoing challenges in reversing the decline in the near term.
High customer churn, especially within the life sciences segment, has weakened net dollar retention. Management flagged continued elevated churn, which could hurt recurring revenue and margin consistency.
Barclays downgraded Definitive Healthcare to Underweight, projecting fiscal 2025 revenue declines and pointing to increased competition from platforms like Veeva Data Cloud, which could further erode market share and pricing power.
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
DH Financial Performance
Revenues and expenses
DH Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Definitive Healthcare stock?
Definitive Healthcare (DH) has a market cap of $309M as of October 22, 2025.
What is the P/E ratio for Definitive Healthcare stock?
The price to earnings (P/E) ratio for Definitive Healthcare (DH) stock is 0 as of October 22, 2025.
Does Definitive Healthcare stock pay dividends?
No, Definitive Healthcare (DH) stock does not pay dividends to its shareholders as of October 22, 2025.
When is the next Definitive Healthcare dividend payment date?
Definitive Healthcare (DH) stock does not pay dividends to its shareholders.
What is the beta indicator for Definitive Healthcare?
Definitive Healthcare (DH) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.